Company news
Cyclerion Therapeutics, Inc. news in 2021
Cyclerion Therapeutics, Inc.'s news releases, calls and decks from 2021, newest first.
Cyclerion Therapeutics Reports Third Quarter 2021 Financial Results and Corporate Update
November 8, 2021
Cyclerion Announces Publication of Preclinical Data Demonstrating Reduction in Neuroinflammation by Brain-Penetrant sGC Stimulator
September 21, 2021
Cyclerion Therapeutics Reports Second Quarter 2021 Financial Results and Corporate Update
July 28, 2021
Cyclerion Therapeutics to Present Clinical Trial Design for CY6463 Phase 2a Study in Participants with Alzheimer’s Disease with Vascular Pathology at the Alzheimer’s Association International Conference 2021 (AAIC)
July 21, 2021
Cyclerion Therapeutics and Beacon Biosignals Announce Expanded Strategic Partnership
July 7, 2021
Cyclerion Therapeutics Announces Global Licensing Agreement with Akebia Therapeutics for Praliciguat
June 3, 2021
Cyclerion Therapeutics Announces $18 Million Private Placement
June 3, 2021
Cyclerion Therapeutics Announces Publication of CY6463 Preclinical Data in Frontiers in Pharmacology
May 26, 2021
Cyclerion Therapeutics Appoints Errol De Souza, Ph.D., to Board of Directors
April 25, 2021
Cyclerion Therapeutics Announces Departure of Chief Medical Officer
March 17, 2021
Cyclerion Therapeutics Reports Full Year 2020 Financial Results and Corporate Update
February 24, 2021
Cyclerion Therapeutics Announces Clinical and Scientific Advisory Boards
January 24, 2021
Decks in 2021
- Investor Presentation (September 2021)
Investor deck · 59 slides · Sep 30, 2021
- Investor Presentation (April 2021)
Investor deck · 59 slides · Apr 27, 2021
- Corporate Update (January 2021)
Corporate update · 37 slides · Jan 13, 2021